Effect of Lorcaserin on Cannabis Withdrawal and Self-administration



Status:Active, not recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:21 - 50
Updated:12/6/2018
Start Date:September 5, 2017
End Date:September 2019

Use our guide to learn which trials are right for you!

In this study, the investigators are interested in testing how lorcaserin influences the
effects of cannabis in a human laboratory model of cannabis use.

In order to improve treatment outcome for cannabis use disorder (CUD), the investigators have
developed a laboratory model to investigate the effects of potential treatment medications on
cannabis withdrawal and on the subjective and reinforcing effects of cannabis in non
treatment-seeking cannabis smokers. In this study, the investigators are interested in
testing how lorcaserin influences the effects of cannabis in a human laboratory model of
cannabis use.

Inclusion Criteria:

- Current cannabis use

- Able to give informed consent and perform study procedures

- Women practicing an effective form of birth control

- English speaking

Exclusion Criteria:

- Presence of any clinically significant medical diagnoses

- History of heart disease and cardiac risk factors, severe chronic obstructive
pulmonary disease, uncontrolled hypertension, or diabetes

- Current parole or probation

- Certain psychiatric diagnoses

- Current pregnancy or lactation
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
646-774-5000
Phone: 646-774-7777
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
?
mi
from
New York, NY
Click here to add this to my saved trials